Ebba Holme Hansen

4.9k citations
143 papers · 3.7k indexed · h-index 34
Topics
Pharmaceutical studies and practices (33 papers)Pharmacovigilance and Adverse Drug Reactions (20 papers)Pharmaceutical Economics and Policy (19 papers)

In The Last Decade

Ebba Holme Hansen

142 papers receiving 3.5k citations

Peers

Ebba Holme Hansen
Comparison fields: 5 of 166
  • Pediatrics, Perinatology and Child Health 941
  • Psychiatry and Mental health 714
  • General Health Professions 650
  • Toxicology 501
  • Economics and Econometrics 434
Replace Ulf Bergman with:
Ulf Bergman Sweden
Almut G. Winterstein United States
Imti Choonara United Kingdom
Simon R. Knowles Australia
Maurizio Bonati Italy
Lolkje T.W. de Jong‐van den Berg Netherlands
Ron M. C. Herings Netherlands
Marja Airaksinen Finland
Eibert R. Heerdink Netherlands
Margaret Watson United Kingdom
Ebba Holme Hansen relative to Ulf Bergman Sweden Ulf Bergman's profile →
Citations per field
00.5×1.5×
Ulf Bergman · 1×
Citations per year

Countries citing papers authored by Ebba Holme Hansen

Since Specialization
Citations

This map shows the geographic impact of Ebba Holme Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebba Holme Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebba Holme Hansen more than expected).

Fields of papers citing papers by Ebba Holme Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebba Holme Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebba Holme Hansen. The network helps show where Ebba Holme Hansen may publish in the future.

Co-authorship network of co-authors of Ebba Holme Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Ebba Holme Hansen. A scholar is included among the top collaborators of Ebba Holme Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebba Holme Hansen. Ebba Holme Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 22
2 6
3 12
4 15
5 23
6 13
7 1
8 31
9
A new indicator based tool for assessing and reporting on good pharmacy practice.
17
10 1
11 92
12 28
13 56
14 24
15 75
16 3
17 36
18
Technology assessment of pharmaceuticals. The necessity of user perspective.
7
19
Clinical trials:towards a different model
2
20
Environmental effects on nematodes in axenic culture.
1

About Ebba Holme Hansen

Ebba Holme Hansen is a scholar working on Toxicology, Family Practice and Geriatrics and Gerontology, having authored 143 papers that have together received 3.7k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (33 papers), Pharmacovigilance and Adverse Drug Reactions (20 papers) and Pharmaceutical Economics and Policy (19 papers). The work is most often cited by research in Toxicology (501 citations), Family Practice (246 citations) and Applied Microbiology and Biotechnology (215 citations). Ebba Holme Hansen has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Lise Aagaard, Bjørn Evald Holstein, Pernille Due, Lise Aagaard, Anette Andersen, Maria Lurenda Westergaard, Charlotte Glümer, Svend‎ Sabroe, Johanna Strandell and Rigmor Jensen. Their work appears in journals such as PLoS ONE, PEDIATRICS and Pain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026